Eupatolide inhibits PDGF-induced proliferation and migration of aortic smooth muscle cells through ROS-dependent heme oxygenase-1 induction.

作者: Namho Kim , Cheol Hwangbo , Suhyun Lee , Jeong-Hyung Lee

DOI: 10.1002/PTR.4924

关键词:

摘要: The abnormal proliferation and migration of vascular smooth muscle cell (VSMC) contributes importantly to the pathogenesis atherosclerosis restenosis. Here, we investigated effects eupatolide (EuTL), a sesquiterpene lactone isolated from medicinal plant Inula britannica, on platelet-derived growth factor (PDGF)-induced primary rat aortic cells (RASMCs), as well its underlying mechanisms. EuTL remarkably inhibited PDGF-induced RASMCs. Treatment RASMCs with induced both protein mRNA expression heme oxygenase-1 (HO-1). SB203580 (a p38 inhibitor), SP600125 JNK U0126 MEK inhibitor) LY294002 PI3K did not suppress EuTL-induced HO-1 expression; however, N-acetylcysteine (NAC, an antioxidant) blocked expression. Moreover, treatment increased reactive oxygen species (ROS) accumulation nuclear translocation factor-E2-related 2 (Nrf2); this was also by NAC. NAC or inhibition significantly attenuated inhibitory Taken together, these findings suggest that could VSMCs through induction via ROS-Nrf2 pathway may be potential inducer for preventing treating diseases. Copyright © 2013 John Wiley & Sons, Ltd.

参考文章(33)
Schwartz Sm, Smooth muscle migration in atherosclerosis and restenosis. Journal of Clinical Investigation. ,vol. 100, pp. 2814- 2817 ,(1997)
Nariman Panahian, Mahin D. Maines, The heme oxygenase system and cellular defense mechanisms Advances in Experimental Medicine and Biology. ,vol. 502, pp. 249- 272 ,(2001) , 10.1007/978-1-4757-3401-0_17
Jongkyu Lee, Nara Tae, Jung Joon Lee, Taeho Kim, Jeong-Hyung Lee, Eupatolide inhibits lipopolysaccharide-induced COX-2 and iNOS expression in RAW264.7 cells by inducing proteasomal degradation of TRAF6 European Journal of Pharmacology. ,vol. 636, pp. 173- 180 ,(2010) , 10.1016/J.EJPHAR.2010.03.021
Makoto Kobayashi, Masayuki Yamamoto, Molecular mechanisms activating the Nrf2-Keap1 pathway of antioxidant gene regulation. Antioxidants & Redox Signaling. ,vol. 7, pp. 385- 394 ,(2005) , 10.1089/ARS.2005.7.385
Ananta Paine, Britta Eiz-Vesper, Rainer Blasczyk, Stephan Immenschuh, Signaling to heme oxygenase-1 and its anti-inflammatory therapeutic potential Biochemical Pharmacology. ,vol. 80, pp. 1895- 1903 ,(2010) , 10.1016/J.BCP.2010.07.014
R. Öllinger, K. Yamashita, Martin Bilban, A. Erat, P. Kogler, M. Thomas, E. Csizmadia, A. Usheva, R. Margreiter, Fritz H. Bach, Bilirubin and biliverdin treatment of atherosclerotic diseases. Cell Cycle. ,vol. 6, pp. 39- 43 ,(2007) , 10.4161/CC.6.1.3700
Simon Fourquet, Raphaël Guerois, Denis Biard, Michel B. Toledano, Activation of NRF2 by Nitrosative Agents and H2O2 Involves KEAP1 Disulfide Formation Journal of Biological Chemistry. ,vol. 285, pp. 8463- 8471 ,(2010) , 10.1074/JBC.M109.051714
Agnieszka Loboda, Agnieszka Jazwa, Anna Grochot-Przeczek, Andrzej J. Rutkowski, Jaroslaw Cisowski, Anupam Agarwal, Alicja Jozkowicz, Jozef Dulak, Heme Oxygenase-1 and the Vascular Bed: From Molecular Mechanisms to Therapeutic Opportunities Antioxidants & Redox Signaling. ,vol. 10, pp. 1767- 1812 ,(2008) , 10.1089/ARS.2008.2043
Stephen J. Peterson, William H. Frishman, Targeting heme oxygenase: therapeutic implications for diseases of the cardiovascular system. Cardiology in Review. ,vol. 17, pp. 99- 111 ,(2009) , 10.1097/CRD.0B013E31819D813A
Atsunori Nakao, Noriko Murase, Chien Ho, Hideyoshi Toyokawa, Timothy R. Billiar, Shinichi Kanno, Biliverdin Administration Prevents the Formation of Intimal Hyperplasia Induced by Vascular Injury Circulation. ,vol. 112, pp. 587- 591 ,(2005) , 10.1161/CIRCULATIONAHA.104.509778